Mark Elwa
All posts from Mark Elwa
Mark Elwa in Gainers & Losers,

Pfizer lifted up full-year 2015 outlook

Today the company raised its full-year 2015 outlook for adjusted EPS to a range of $2.16 to $2.20 from $2.04 to $2.10, and for revenue to $47.5 billion to $48.5 billion from $46.5 billion to $47.5 billion.

So i think stocks will rise today. They are trading in a wedge with resistance at $35-35.5 per share